nodes	percent_of_prediction	percent_of_DWPC	metapath
Indacaterol—UGT1A1—Sorafenib—thyroid cancer	0.46	0.586	CbGbCtD
Indacaterol—ABCB1—Sorafenib—thyroid cancer	0.0912	0.116	CbGbCtD
Indacaterol—CYP3A4—Vandetanib—thyroid cancer	0.0907	0.116	CbGbCtD
Indacaterol—ABCB1—Doxorubicin—thyroid cancer	0.0554	0.0705	CbGbCtD
Indacaterol—CYP3A4—Sorafenib—thyroid cancer	0.0547	0.0696	CbGbCtD
Indacaterol—CYP3A4—Doxorubicin—thyroid cancer	0.0332	0.0422	CbGbCtD
Indacaterol—Myocardial ischaemia—Sorafenib—thyroid cancer	0.00573	0.0267	CcSEcCtD
Indacaterol—Rhinorrhoea—Sorafenib—thyroid cancer	0.00569	0.0265	CcSEcCtD
Indacaterol—Atrial fibrillation—Vandetanib—thyroid cancer	0.00523	0.0243	CcSEcCtD
Indacaterol—Hypokalaemia—Vandetanib—thyroid cancer	0.00451	0.021	CcSEcCtD
Indacaterol—Nasopharyngitis—Vandetanib—thyroid cancer	0.00443	0.0206	CcSEcCtD
Indacaterol—Bronchospasm—Vandetanib—thyroid cancer	0.00421	0.0196	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Vandetanib—thyroid cancer	0.00398	0.0185	CcSEcCtD
Indacaterol—Hyperglycaemia—Vandetanib—thyroid cancer	0.00386	0.018	CcSEcCtD
Indacaterol—Pneumonia—Vandetanib—thyroid cancer	0.00384	0.0179	CcSEcCtD
Indacaterol—Infestation—Vandetanib—thyroid cancer	0.00382	0.0178	CcSEcCtD
Indacaterol—Infestation NOS—Vandetanib—thyroid cancer	0.00382	0.0178	CcSEcCtD
Indacaterol—Sinusitis—Vandetanib—thyroid cancer	0.00358	0.0167	CcSEcCtD
Indacaterol—Cardiac disorder—Vandetanib—thyroid cancer	0.00318	0.0148	CcSEcCtD
Indacaterol—Mediastinal disorder—Vandetanib—thyroid cancer	0.00309	0.0144	CcSEcCtD
Indacaterol—Hypokalaemia—Sorafenib—thyroid cancer	0.00304	0.0142	CcSEcCtD
Indacaterol—Nasopharyngitis—Sorafenib—thyroid cancer	0.00299	0.0139	CcSEcCtD
Indacaterol—Malnutrition—Vandetanib—thyroid cancer	0.00299	0.0139	CcSEcCtD
Indacaterol—Muscle spasms—Vandetanib—thyroid cancer	0.00287	0.0134	CcSEcCtD
Indacaterol—Tremor—Vandetanib—thyroid cancer	0.0028	0.013	CcSEcCtD
Indacaterol—Cough—Vandetanib—thyroid cancer	0.0026	0.0121	CcSEcCtD
Indacaterol—Pneumonia—Sorafenib—thyroid cancer	0.00259	0.0121	CcSEcCtD
Indacaterol—Infestation NOS—Sorafenib—thyroid cancer	0.00258	0.012	CcSEcCtD
Indacaterol—Infestation—Sorafenib—thyroid cancer	0.00258	0.012	CcSEcCtD
Indacaterol—Chest pain—Vandetanib—thyroid cancer	0.00254	0.0118	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00252	0.0117	CcSEcCtD
Indacaterol—Dry mouth—Vandetanib—thyroid cancer	0.00249	0.0116	CcSEcCtD
Indacaterol—Infection—Vandetanib—thyroid cancer	0.00242	0.0113	CcSEcCtD
Indacaterol—Nervous system disorder—Vandetanib—thyroid cancer	0.00239	0.0111	CcSEcCtD
Indacaterol—Skin disorder—Vandetanib—thyroid cancer	0.00237	0.011	CcSEcCtD
Indacaterol—Connective tissue disorder—Sorafenib—thyroid cancer	0.00227	0.0106	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00222	0.0103	CcSEcCtD
Indacaterol—Paraesthesia—Vandetanib—thyroid cancer	0.00219	0.0102	CcSEcCtD
Indacaterol—Dyspnoea—Vandetanib—thyroid cancer	0.00217	0.0101	CcSEcCtD
Indacaterol—Cardiac disorder—Sorafenib—thyroid cancer	0.00215	0.00999	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.0021	0.00979	CcSEcCtD
Indacaterol—Immune system disorder—Sorafenib—thyroid cancer	0.00209	0.00972	CcSEcCtD
Indacaterol—Mediastinal disorder—Sorafenib—thyroid cancer	0.00208	0.0097	CcSEcCtD
Indacaterol—Malnutrition—Sorafenib—thyroid cancer	0.00201	0.00937	CcSEcCtD
Indacaterol—Muscle spasms—Sorafenib—thyroid cancer	0.00194	0.00901	CcSEcCtD
Indacaterol—Anaemia—Sorafenib—thyroid cancer	0.00186	0.00866	CcSEcCtD
Indacaterol—Cough—Sorafenib—thyroid cancer	0.00176	0.00818	CcSEcCtD
Indacaterol—Pruritus—Vandetanib—thyroid cancer	0.00172	0.00802	CcSEcCtD
Indacaterol—Musculoskeletal pain—Epirubicin—thyroid cancer	0.00172	0.00802	CcSEcCtD
Indacaterol—Myalgia—Sorafenib—thyroid cancer	0.00171	0.00798	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.0017	0.00792	CcSEcCtD
Indacaterol—Dry mouth—Sorafenib—thyroid cancer	0.00168	0.0078	CcSEcCtD
Indacaterol—Infection—Sorafenib—thyroid cancer	0.00163	0.0076	CcSEcCtD
Indacaterol—Nervous system disorder—Sorafenib—thyroid cancer	0.00161	0.0075	CcSEcCtD
Indacaterol—Dizziness—Vandetanib—thyroid cancer	0.00161	0.0075	CcSEcCtD
Indacaterol—Skin disorder—Sorafenib—thyroid cancer	0.0016	0.00743	CcSEcCtD
Indacaterol—Musculoskeletal pain—Doxorubicin—thyroid cancer	0.00159	0.00742	CcSEcCtD
Indacaterol—Rash—Vandetanib—thyroid cancer	0.00154	0.00715	CcSEcCtD
Indacaterol—Dermatitis—Vandetanib—thyroid cancer	0.00153	0.00714	CcSEcCtD
Indacaterol—Headache—Vandetanib—thyroid cancer	0.00153	0.0071	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.0015	0.00697	CcSEcCtD
Indacaterol—Dyspnoea—Sorafenib—thyroid cancer	0.00147	0.00682	CcSEcCtD
Indacaterol—Nausea—Vandetanib—thyroid cancer	0.00145	0.00673	CcSEcCtD
Indacaterol—Diabetes mellitus—Epirubicin—thyroid cancer	0.00142	0.00661	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00142	0.0066	CcSEcCtD
Indacaterol—Diabetes mellitus—Doxorubicin—thyroid cancer	0.00131	0.00612	CcSEcCtD
Indacaterol—Hypersensitivity—Sorafenib—thyroid cancer	0.00121	0.00564	CcSEcCtD
Indacaterol—Pruritus—Sorafenib—thyroid cancer	0.00116	0.00541	CcSEcCtD
Indacaterol—Hypokalaemia—Epirubicin—thyroid cancer	0.00112	0.00523	CcSEcCtD
Indacaterol—Nasopharyngitis—Epirubicin—thyroid cancer	0.00111	0.00514	CcSEcCtD
Indacaterol—Dizziness—Sorafenib—thyroid cancer	0.00109	0.00506	CcSEcCtD
Indacaterol—Asthma—Epirubicin—thyroid cancer	0.00107	0.00497	CcSEcCtD
Indacaterol—Hypokalaemia—Doxorubicin—thyroid cancer	0.00104	0.00484	CcSEcCtD
Indacaterol—Angina pectoris—Epirubicin—thyroid cancer	0.00104	0.00484	CcSEcCtD
Indacaterol—Rash—Sorafenib—thyroid cancer	0.00104	0.00482	CcSEcCtD
Indacaterol—Dermatitis—Sorafenib—thyroid cancer	0.00104	0.00482	CcSEcCtD
Indacaterol—Headache—Sorafenib—thyroid cancer	0.00103	0.00479	CcSEcCtD
Indacaterol—Nasopharyngitis—Doxorubicin—thyroid cancer	0.00102	0.00476	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000993	0.00462	CcSEcCtD
Indacaterol—Asthma—Doxorubicin—thyroid cancer	0.000988	0.0046	CcSEcCtD
Indacaterol—Nausea—Sorafenib—thyroid cancer	0.000976	0.00454	CcSEcCtD
Indacaterol—Hyperglycaemia—Epirubicin—thyroid cancer	0.000963	0.00448	CcSEcCtD
Indacaterol—Angina pectoris—Doxorubicin—thyroid cancer	0.000963	0.00448	CcSEcCtD
Indacaterol—Pneumonia—Epirubicin—thyroid cancer	0.000958	0.00446	CcSEcCtD
Indacaterol—Infestation NOS—Epirubicin—thyroid cancer	0.000952	0.00443	CcSEcCtD
Indacaterol—Infestation—Epirubicin—thyroid cancer	0.000952	0.00443	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000918	0.00427	CcSEcCtD
Indacaterol—Sinusitis—Epirubicin—thyroid cancer	0.000893	0.00416	CcSEcCtD
Indacaterol—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000891	0.00415	CcSEcCtD
Indacaterol—Pneumonia—Doxorubicin—thyroid cancer	0.000886	0.00412	CcSEcCtD
Indacaterol—Infestation—Doxorubicin—thyroid cancer	0.000881	0.0041	CcSEcCtD
Indacaterol—Infestation NOS—Doxorubicin—thyroid cancer	0.000881	0.0041	CcSEcCtD
Indacaterol—Oedema peripheral—Epirubicin—thyroid cancer	0.000842	0.00392	CcSEcCtD
Indacaterol—Connective tissue disorder—Epirubicin—thyroid cancer	0.00084	0.00391	CcSEcCtD
Indacaterol—Sinusitis—Doxorubicin—thyroid cancer	0.000827	0.00385	CcSEcCtD
Indacaterol—Cardiac disorder—Epirubicin—thyroid cancer	0.000793	0.00369	CcSEcCtD
Indacaterol—Oedema peripheral—Doxorubicin—thyroid cancer	0.000779	0.00363	CcSEcCtD
Indacaterol—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000777	0.00362	CcSEcCtD
Indacaterol—Immune system disorder—Epirubicin—thyroid cancer	0.000772	0.00359	CcSEcCtD
Indacaterol—Mediastinal disorder—Epirubicin—thyroid cancer	0.00077	0.00359	CcSEcCtD
Indacaterol—Malnutrition—Epirubicin—thyroid cancer	0.000744	0.00346	CcSEcCtD
Indacaterol—Cardiac disorder—Doxorubicin—thyroid cancer	0.000734	0.00342	CcSEcCtD
Indacaterol—Muscle spasms—Epirubicin—thyroid cancer	0.000715	0.00333	CcSEcCtD
Indacaterol—Immune system disorder—Doxorubicin—thyroid cancer	0.000714	0.00333	CcSEcCtD
Indacaterol—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000713	0.00332	CcSEcCtD
Indacaterol—Malnutrition—Doxorubicin—thyroid cancer	0.000689	0.0032	CcSEcCtD
Indacaterol—Anaemia—Epirubicin—thyroid cancer	0.000688	0.0032	CcSEcCtD
Indacaterol—Vertigo—Epirubicin—thyroid cancer	0.000669	0.00311	CcSEcCtD
Indacaterol—Muscle spasms—Doxorubicin—thyroid cancer	0.000662	0.00308	CcSEcCtD
Indacaterol—Palpitations—Epirubicin—thyroid cancer	0.000658	0.00306	CcSEcCtD
Indacaterol—Cough—Epirubicin—thyroid cancer	0.000649	0.00302	CcSEcCtD
Indacaterol—Anaemia—Doxorubicin—thyroid cancer	0.000636	0.00296	CcSEcCtD
Indacaterol—Chest pain—Epirubicin—thyroid cancer	0.000634	0.00295	CcSEcCtD
Indacaterol—Myalgia—Epirubicin—thyroid cancer	0.000634	0.00295	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000629	0.00293	CcSEcCtD
Indacaterol—Dry mouth—Epirubicin—thyroid cancer	0.00062	0.00288	CcSEcCtD
Indacaterol—Vertigo—Doxorubicin—thyroid cancer	0.000619	0.00288	CcSEcCtD
Indacaterol—Palpitations—Doxorubicin—thyroid cancer	0.000609	0.00283	CcSEcCtD
Indacaterol—Infection—Epirubicin—thyroid cancer	0.000603	0.00281	CcSEcCtD
Indacaterol—Cough—Doxorubicin—thyroid cancer	0.000601	0.0028	CcSEcCtD
Indacaterol—Nervous system disorder—Epirubicin—thyroid cancer	0.000596	0.00277	CcSEcCtD
Indacaterol—Tachycardia—Epirubicin—thyroid cancer	0.000593	0.00276	CcSEcCtD
Indacaterol—Skin disorder—Epirubicin—thyroid cancer	0.00059	0.00275	CcSEcCtD
Indacaterol—Chest pain—Doxorubicin—thyroid cancer	0.000586	0.00273	CcSEcCtD
Indacaterol—Myalgia—Doxorubicin—thyroid cancer	0.000586	0.00273	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000582	0.00271	CcSEcCtD
Indacaterol—Dry mouth—Doxorubicin—thyroid cancer	0.000573	0.00267	CcSEcCtD
Indacaterol—Infection—Doxorubicin—thyroid cancer	0.000558	0.0026	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000553	0.00258	CcSEcCtD
Indacaterol—Nervous system disorder—Doxorubicin—thyroid cancer	0.000551	0.00256	CcSEcCtD
Indacaterol—Tachycardia—Doxorubicin—thyroid cancer	0.000548	0.00255	CcSEcCtD
Indacaterol—Skin disorder—Doxorubicin—thyroid cancer	0.000546	0.00254	CcSEcCtD
Indacaterol—Paraesthesia—Epirubicin—thyroid cancer	0.000545	0.00254	CcSEcCtD
Indacaterol—Dyspnoea—Epirubicin—thyroid cancer	0.000541	0.00252	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000524	0.00244	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000512	0.00238	CcSEcCtD
Indacaterol—Paraesthesia—Doxorubicin—thyroid cancer	0.000505	0.00235	CcSEcCtD
Indacaterol—Dyspnoea—Doxorubicin—thyroid cancer	0.000501	0.00233	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000485	0.00226	CcSEcCtD
Indacaterol—Hypersensitivity—Epirubicin—thyroid cancer	0.000447	0.00208	CcSEcCtD
Indacaterol—Pruritus—Epirubicin—thyroid cancer	0.00043	0.002	CcSEcCtD
Indacaterol—Hypersensitivity—Doxorubicin—thyroid cancer	0.000414	0.00193	CcSEcCtD
Indacaterol—Dizziness—Epirubicin—thyroid cancer	0.000402	0.00187	CcSEcCtD
Indacaterol—Pruritus—Doxorubicin—thyroid cancer	0.000398	0.00185	CcSEcCtD
Indacaterol—Rash—Epirubicin—thyroid cancer	0.000383	0.00178	CcSEcCtD
Indacaterol—Dermatitis—Epirubicin—thyroid cancer	0.000383	0.00178	CcSEcCtD
Indacaterol—Headache—Epirubicin—thyroid cancer	0.00038	0.00177	CcSEcCtD
Indacaterol—Dizziness—Doxorubicin—thyroid cancer	0.000372	0.00173	CcSEcCtD
Indacaterol—Nausea—Epirubicin—thyroid cancer	0.000361	0.00168	CcSEcCtD
Indacaterol—Rash—Doxorubicin—thyroid cancer	0.000354	0.00165	CcSEcCtD
Indacaterol—Dermatitis—Doxorubicin—thyroid cancer	0.000354	0.00165	CcSEcCtD
Indacaterol—Headache—Doxorubicin—thyroid cancer	0.000352	0.00164	CcSEcCtD
Indacaterol—Nausea—Doxorubicin—thyroid cancer	0.000334	0.00155	CcSEcCtD
